VANGUARD GROUP INC 13D and 13G filings for Novavax, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:46 pm Unchanged | 2024-09-30 | 13G | Novavax, Inc. NVAX | VANGUARD GROUP INC | 15,430,034 9.630% | 0 (Unchanged) | Filing |
| 2024-11-04 1:19 pm Purchase | 2024-09-30 | 13G | Novavax, Inc. NVAX | VANGUARD GROUP INC | 15,430,034 9.630% | 869,980 (+5.98%) | Filing |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Novavax, Inc. NVAX | VANGUARD GROUP INC | 14,560,054 12.260% | 5,715,401 (+64.62%) | Filing |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | Novavax, Inc. NVAX | VANGUARD GROUP INC | 8,844,653 10.410% | 852,425 (+10.67%) | Filing |
| 2022-12-12 3:09 pm Purchase | 2022-11-30 | 13G | Novavax, Inc. NVAX | VANGUARD GROUP INC | 7,992,228 10.180% | 1,095,221 (+15.88%) | Filing |
| 2022-02-10 08:28 am Purchase | 2021-12-31 | 13G | Novavax, Inc. NVAX | VANGUARD GROUP INC | 6,897,007 9.120% | 1,298,247 (+23.19%) | Filing |
| 2021-02-10 11:40 am Purchase | 2020-12-31 | 13G | Novavax, Inc. NVAX | VANGUARD GROUP INC | 5,598,760 8.790% | 4,116,901 (+277.82%) | Filing |